KCNH2 and gastric cancer: Within the KV family, KV11.1 (hERG) shows altered expression in an array of cancer types and has been shown to impact cellular proliferation (melanoma, colorectal cancer and Barrett's esophagus), migration (melanoma, thyroid and breast cancer), malignant transformation (head & neck carcinoma) and apoptosis (gastric cancer).